Genmab A/S (GMAB)

Genmab Revenue

Genmab had revenue of $896.00M in the quarter ending March 31, 2026, with 25.31% growth. This brings the company's revenue in the last twelve months to $3.90B, up 27.49% year-over-year. In the year 2025, Genmab had annual revenue of $3.72B with 19.19% growth.

• Revenue (ttm): $3.90B
• Revenue Growth: +27.49%
• P/S Ratio: 4.21
• Revenue / Employee: $1,263,277
• Employees: 3,088
• Market Cap: 16.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.72B	599.00M	19.19%
Dec 31, 2024	3.12B	731.00M	30.59%
Dec 31, 2023	2.39B	302.26M	14.48%
Dec 31, 2022	2.09B	800.56M	62.19%
Dec 31, 2021	1.29B	-372.56M	-22.45%
Dec 31, 2020	1.66B	854.42M	106.10%
Dec 31, 2019	805.32M	340.75M	73.35%
Dec 31, 2018	464.57M	83.44M	21.89%
Dec 31, 2017	381.13M	123.38M	47.87%
Dec 31, 2016	257.75M	92.65M	56.12%
Dec 31, 2015	165.10M	26.80M	19.38%
Dec 31, 2014	138.30M	15.94M	13.02%
Dec 31, 2013	122.37M	36.66M	42.77%
Dec 31, 2012	85.70M	24.59M	40.23%
Dec 31, 2011	61.12M	-43.27M	-41.45%
Dec 31, 2010	104.39M	-8.77M	-7.75%
Dec 31, 2009	113.16M	-16.25M	-12.56%
Dec 31, 2008	129.42M	25.30M	24.29%
Dec 31, 2007	104.12M	80.20M	335.29%
Dec 31, 2006	23.92M	8.33M	53.41%
Dec 31, 2005	15.59M	-	-

Data Source: Fiscal.ai Last updated: May 8, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error